EDAP TMS SA (NASDAQ:EDAP) — Market Cap & Net Worth
Market Cap & Net Worth: EDAP TMS SA (EDAP)
EDAP TMS SA (NASDAQ:EDAP) has a market capitalization of $154.80 Million ($154.80 Million) as of June 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #17627 globally and #4096 in its home market, demonstrating a 1.71% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying EDAP TMS SA's stock price $4.77 by its total outstanding shares 37481986 (37.48 Million). Review EDAP liabilities breakdown to assess the company's total debt and financial obligations.
EDAP TMS SA Market Cap History: 2015 to 2026
EDAP TMS SA's market capitalization history from 2015 to 2026. Data shows growth from $154.80 Million to $178.79 Million (0.34% CAGR).
Index Memberships
EDAP TMS SA is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.42 Trillion | 0.01% | #491 of 976 |
|
NASDAQ Composite
IXIC
|
$40.74 Trillion | 0.00% | #1729 of 3165 |
Weight: EDAP TMS SA's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
EDAP TMS SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how EDAP TMS SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.74x
EDAP TMS SA's market cap is 1.74 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $122.94 Million | $35.61 Million | $3.84 Million | 3.45x | 32.00x |
| 2017 | $107.57 Million | $35.75 Million | -$681.00K | 3.01x | N/A |
| 2018 | $69.34 Million | $39.18 Million | -$338.00K | 1.77x | N/A |
| 2019 | $166.05 Million | $44.91 Million | $1.51 Million | 3.70x | 109.82x |
| 2020 | $193.78 Million | $41.66 Million | -$1.70 Million | 4.65x | N/A |
| 2021 | $224.52 Million | $44.07 Million | $700.00K | 5.10x | 320.74x |
| 2022 | $399.56 Million | $55.11 Million | -$2.93 Million | 7.25x | N/A |
| 2023 | $197.90 Million | $60.42 Million | -$21.18 Million | 3.28x | N/A |
| 2024 | $82.84 Million | $64.11 Million | -$19.02 Million | 1.29x | N/A |
| 2025 | $123.32 Million | $70.75 Million | -$29.34 Million | 1.74x | N/A |
Competitor Companies of EDAP by Market Capitalization
Companies near EDAP TMS SA in the global market cap rankings as of June 19, 2026.
Key companies related to EDAP TMS SA by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #271 globally with a market cap of $93.74 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #539 globally with a market cap of $50.53 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #642 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1154 globally with a market cap of $22.95 Billion USD ( AU$32.44 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #271 | McKesson Corporation | NYSE:MCK | $93.74 Billion | $779.80 |
| #539 | Cencora Inc. | NYSE:COR | $50.53 Billion | $277.09 |
| #642 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $226.28 |
| #1154 | Sigma Healthcare Ltd | AU:SIG | $22.95 Billion | AU$2.81 |
EDAP TMS SA Historical Marketcap From 2015 to 2026
Between 2015 and today, EDAP TMS SA's market cap moved from $154.80 Million to $ 178.79 Million, with a yearly change of 0.34%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $178.79 Million | +44.98% |
| 2025 | $123.32 Million | +48.87% |
| 2024 | $82.84 Million | -58.14% |
| 2023 | $197.90 Million | -50.47% |
| 2022 | $399.56 Million | +77.96% |
| 2021 | $224.52 Million | +15.86% |
| 2020 | $193.78 Million | +16.70% |
| 2019 | $166.05 Million | +139.46% |
| 2018 | $69.34 Million | -35.54% |
| 2017 | $107.57 Million | -12.50% |
| 2016 | $122.94 Million | -20.58% |
| 2015 | $154.80 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of EDAP TMS SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $154.80 Million USD |
| MoneyControl | $154.80 Million USD |
| MarketWatch | $154.80 Million USD |
| marketcap.company | $154.80 Million USD |
| Reuters | $154.80 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About EDAP TMS SA
EDAP TMS S.A., a medical technology company, engages in the development, manufacturing, marketing, and sale of non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments. The HIFU segment de… Read more